MARKET

RAPH

RAPH

Raphael Pharm
OTCMQB
1.400
NaN%
Opening 09:30 02/09 EST
OPEN
--
PREV CLOSE
1.400
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
1.400
52 WEEK LOW
0.150
MARKET CAP
27.48M
P/E (TTM)
-19.3370
1D
5D
1M
3M
1Y
5Y
1D
Raphael Pharmaceutical Announces Filing of Provisional Patent Application for the Treatment of Neutrophil-Dominant Autoimmune Diseases, Including Rheumatoid Arthritis (RA)
Barchart · 11/17/2025 11:03
Weekly Report: what happened at RAPH last week (0908-0912)?
Weekly Report · 09/15/2025 11:51
Raphael Pharmaceutical Inc. Files Initial Statement of Beneficial Ownership for Director Zvi Laufer
Reuters · 09/08/2025 20:29
Weekly Report: what happened at RAPH last week (0901-0905)?
Weekly Report · 09/08/2025 11:53
Weekly Report: what happened at RAPH last week (0825-0829)?
Weekly Report · 09/01/2025 11:47
Weekly Report: what happened at RAPH last week (0818-0822)?
Weekly Report · 08/25/2025 12:01
Weekly Report: what happened at RAPH last week (0811-0815)?
Weekly Report · 08/18/2025 11:51
Raphael Pharmaceutical Inc. Announces Board Changes: Dr. Igal Louria Hayon Resigns, Zvi Laufer Laor Appointed as New Director
Reuters · 08/11/2025 20:08
More
About RAPH
Raphael Pharmaceutical Inc. is a pharmaceutical drug research and development company. The Company is focused on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol (CBD) oil. The Company has completed the study for its lead product candidate for the treatment of rheumatoid arthritis (RA), and is developing asthma product candidates, which are in the pre-clinical-stage. The Company is also continuing to investigate its product for the treatment of autoimmune diseases. The Company’s discovery platform focuses on the use of CBD oil, one of the cannabinoids in cannabis plants, as the active pharmaceutical ingredient (API), for its RA product candidate and COVID-19 product candidate.

Webull offers Raphael Pharmaceutical Inc stock information, including OTCMQB: RAPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RAPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RAPH stock methods without spending real money on the virtual paper trading platform.